Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of France

Zoé Van de Wyngaert, Eileen M. Boyle, Hélène Demarquette et al.|Blood|2018

Cited by 6